[Federal Register Volume 65, Number 229 (Tuesday, November 28, 2000)]
[Notices]
[Pages 70923-70924]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30163]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(6) and 552b(c)(9), 
Title 5 U.S.C., as amended. The discussions could disclose personal 
information concerning NCI Staff and/or its contractors, the disclosure 
of which would constitute a clearly unwarranted invasion of personal 
privacy, and the premature disclosure of discussions related to 
personnel and programmatic issues which would be likely to 
significantly frustrate the subsequent implementation of 
recommendations.

    Name of Committee: National Cancer Advisory Board.
    Dates: December 4-6, 2000.
    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Planning and Budget.
    Open: December 4, 7:00 p.m. to 8:30 p.m.
    Agenda: To discuss activities related to the NCI Planning and 
Budget process for FY 2001-2002.
    Place: Bethesda Hyatt Regency, One Bethesda Metro Center, 
Bethesda, MD 20814, (301) 657-1234.
    Contact Person: Ms. Cherie Nichols, Executive Secretary, 
National Cancer Institute, National Institutes of Health, (301) 496-
5515.

    Name of Committee: National Cancer Advisory Board.
    Open: December 5, 8:45 a.m. to 11:45 a.m.
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups, http://deainfo.nci.nih.gov/ADVISORY/boards.htm. Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.

    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Clinical Investigations.
    Open: December 5, 11:50 a.m. to 12:20 p.m.
    Agenda: To discuss activities related to the Subcommittee on 
Clinical Investigations.

[[Page 70924]]

    Contact Person: Dr. Ellen Feigal, Acting Executive Secretary, 
National Cancer Institute, National Institutes of Health, (301) 496-
2522.

    Name of Committee: National Cancer Advisory Board, Ad Hoc 
Subcommittee on Communications.
    Closed: December 5, 12:20 p.m. to 12:55 p.m.
    Agenda: To discuss information of a proprietary and/or personal 
nature regarding the proposed structure of communication activities 
within the NCI.
    Contact Person: Dr. Susan Sieber, Executive Secretary, National 
Cancer Institute, National Institutes of Health, (301) 496-5946.

    Name of Committee: National Cancer Advisory Board.
    Open: December 5, 1:00 p.m. to 4:10 p.m.
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups, http://deainfo.nci.nih.gov/ADVISORY/boards.htm. Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.
    Closed: December 5, 4:20 p.m. to Recess.
    Agenda: To review and evaluate intramural research projects and 
discuss information of a personal and confidential nature.
    Open: December 6, 8:45 a.m. to Adjournment (About 12:00 p.m.).
    Agenda: Program reports and presentations; Business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups, http://deainfo.nci.nih.gov/ADVISORY/boards.htm. Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.
    Place: Building 31, C Wing, 6 Floor, Conference Room 10, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 
20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327, 
(301) 496-5147.

    This meeting is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Dated: November 16, 2000.
Laverne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-30163 Filed 11-27-00; 8:45 am]
BILLING CODE 4140-01-M